About Paragon Genomics
Paragon Genomics is a company based in San Francisco (United States) founded in 2015.. Paragon Genomics has raised $8 million across 1 funding round from investors including Geintech Technologies, Wisemont Capital and Co-win Ventures. The company has 26 employees as of December 31, 2022. Paragon Genomics operates in a competitive market with competitors including RareCyte, Sequenta, seqWell, Neogen and LGC, among others.
- Headquarter San Francisco, United States
- Employees 26 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Paragon Genomics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8 M (USD)
in 1 rounds
-
Latest Funding Round
$8 M (USD), Series A
Sep 12, 2017
-
Investors
Geintech Technologies
& 4 more
-
Employee Count
26
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Paragon Genomics
Paragon Genomics has successfully raised a total of $8M through 1 strategic funding round. The most recent funding activity was a Series A round of $8 million completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $8.0M
-
First Round
First Round
(12 Sep 2017)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2017 | Amount | Series A - Paragon Genomics | Valuation | Co-win Ventures , Fosun·Star Future Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Paragon Genomics
Paragon Genomics has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Geintech Technologies, Wisemont Capital and Co-win Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Geintech Technologies is engaged in manufacturing high-standard communication cables.
|
Founded Year | Domain | Location | |
|
US focused seed & early stage VC firm
|
Founded Year | Domain | Location | |
|
VC fund investing in startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Paragon Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Paragon Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Paragon Genomics Comparisons
Competitors of Paragon Genomics
Paragon Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RareCyte, Sequenta, seqWell, Neogen and LGC, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| domain | founded_year | HQ Location |
Immuno-sequencing products are developed for disease diagnostics and treatment.
|
|
| domain | founded_year | HQ Location |
NGS-based reagents and kits are supplied for life sciences research.
|
|
| domain | founded_year | HQ Location |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| domain | founded_year | HQ Location |
Molecular biology reagents and services are supplied to biotech industries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Paragon Genomics
Frequently Asked Questions about Paragon Genomics
When was Paragon Genomics founded?
Paragon Genomics was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Paragon Genomics located?
Paragon Genomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Paragon Genomics a funded company?
Paragon Genomics is a funded company, having raised a total of $8M across 1 funding round to date. The company's 1st funding round was a Series A of $8M, raised on Sep 12, 2017.
How many employees does Paragon Genomics have?
As of Dec 31, 2022, the latest employee count at Paragon Genomics is 26.
What does Paragon Genomics do?
Paragon Genomics was founded in 2015 and is headquartered in San Francisco, United States. Patented targeted sequencing technologies, including CleanPlex DNA, CleanPlex RNA, CleanPlex UMI, and OmniFusion, are developed by the company. Comprehensive solutions are offered in the genomics sector for applications such as precision oncology, infectious disease testing, inherited disease testing, single-cell analysis, and molecular breeding. Operations focus on advancing research and precision medicine worldwide.
Who are the top competitors of Paragon Genomics?
Paragon Genomics's top competitors include Neogen, Biotangents and LGC.
Who are Paragon Genomics's investors?
Paragon Genomics has 5 investors. Key investors include Geintech Technologies, Wisemont Capital, Co-win Ventures, Cloudstone Capital, and Fosun·Star Future Capital.